Covishield 3rd dose increases antibody response against Omicron: Study - Video
|
Overview
A third dose of AstraZeneca's Covid vaccine, named Covishield in India, increases antibody response to the new vaccine-evading Omicron variant, according to a new trial published by the British-Swedish drugmaker on Thursday.
The trial showed the third dose booster also increases the immune response to Beta, Delta, Alpha, and Gamma SARS-CoV-2 variants.
For more information check out the full story on the link below:
Covishield 3rd dose increases antibody response against Omicron, says Study
Speakers
Roshni Dhar, a Mass com graduate with a soft corner for health happenings, joined Medical Dialogues as a news anchor in 2021. Inspired by her mother who is a gynaecologist, she likes to keep herself and the world updated on the occurring in the medical field. She covers various aspects of health news for MDTV at Medical Dialogues. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751